Inquilinus limosus is a novel Gram-negative bacterium of the subdivision α-Proteobacteria recently found in the airways of patients with cystic fibrosis (CF). Here, the authors report on the clinical courses of six CF patients colonized with I. limosus. Five patients suffered from either an acute respiratory exacerbation or a progressive loss of pulmonary function, whereas one patient was in a stable clinical situation. This study focused on two aims: (i) the clonal analysis of I. limosus isolates by random amplified polymorphic DNA (RAPD)-PCR, and (ii) the clarification of whether the presence of I. limosus in the respiratory tract is associated with a specific serum antibody response. Serum IgG was detected by immunoblotting using I. limosus whole-cell-lysate proteins as antigens. Sera from healthy blood donors (n=10) and from CF patients colonized with Pseudomonas aeruginosa (n=10) were found to be immunoblot negative. All six Inquilinus-positive patients raised serum IgG antibodies against various I. limosus antigens. Surprisingly, in one patient, a specific I. limosus serum antibody response was already detected 1 year prior to Inquilinus-positive sputum cultures. Two prominent antigens were characterized by MALDI-MS: a 23 kDa protein revealed homology to the outer membrane lipoprotein OmlA of Actinobacillus pleuropneumoniae, and an 18 kDa protein to a protein-tyrosine phosphatase of Burkholderia cepacia. In conclusion, detection of I. limosus is accompanied by a specific serum antibody response and may reflect the infectious/pathogenic potential of I. limosus. Moreover, IgG immunoblotting may be useful to detect early infection with I. limosus and may support the selective cultivation of this novel emerging pathogen.
BeringerP. M.,
ApplemanM. D.2000; Unusual respiratory bacterial flora in cystic fibrosis: microbiologic and clinical features. Curr Opin Pulm Med 6:545–550[CrossRef]
BurnsJ. L.,
EmersonJ.,
StappJ. R.,
YimD. L.,
KrzewinskiJ.,
LoudenL.,
RamseyB. W.,
ClausenC. R.1998; Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 27:158–163[CrossRef]
CaballeroE.,
DrobnicM. E.,
PerezM. T.,
ManresaJ. M.,
FerrerA.,
OrriolsR.2001; Anti- Pseudomonas aeruginosa antibody detection in patients with bronchiectasis without cystic fibrosis. Thorax 56:669–674[CrossRef]
ChironR.,
MarchandinH.,
CounilF. & 8 other authors; 2005; Clinical and microbiological features of Inquilinus sp. isolates from five patients with cystic fibrosis. J Clin Microbiol 43:3938–3943[CrossRef]
CoenyeT.,
VandammeP.,
LiPumaJ. J.2002b; Infection by Ralstonia species in cystic fibrosis patients: identification of R. pickettii and R. mannitolilytica by polymerase chain reaction. Emerg Infect Dis 8:692–696[CrossRef]
GramT.,
AhrensP.1998; Improved diagnostic PCR assay for Actinobacillus pleuropneumoniae based on the nucleotide sequence of an outer membrane lipoprotein. J Clin Microbiol 36:443–448
HogardtM.,
TrebesiusK.,
GeigerA. M.,
HornefM.,
RoseneckerJ.,
HeesemannJ.2000; Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients. J Clin Microbiol 38:818–825
JohansenH. K.,
NorregaardL.,
GotzscheP. C.,
PresslerT.,
KochC.,
HoibyN.2004; Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success? – A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection. Pediatr Pulmonol 37:427–432[CrossRef]
JorgensenI. M.,
JohansenH. K.,
FrederiksenB.,
PresslerT.,
HansenA.,
VandammeP.,
HoibyN.,
KochC.2003; Epidemic spread of Pandoraea apista , a new pathogen causing severe lung disease in cystic fibrosis patients. Pediatr Pulmonol 36:439–446[CrossRef]
LacyD. E.,
SmithA. W.,
StableforthD. E.,
SmithG.,
WellerP. H.,
BrownM. R.1995; Serum IgG response to Burkholderia cepacia outer membrane antigens in cystic fibrosis: assessment of cross-reactivity with Pseudomonas aeruginosa
. FEMS Immunol Med Microbiol 10:253–261[CrossRef]
MahenthiralingamE.,
CampbellM. E.,
FosterJ.,
LamJ. S.,
SpeertD. P.1996; Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J Clin Microbiol 34:1129–1135
MooreJ. E.,
XuJ.,
MillarB. C.,
CroweM.,
ElbornJ. S.2002; Improved molecular detection of Burkholderia cepacia genomovar III and Burkholderia multivorans directly from sputum of patients with cystic fibrosis. J Microbiol Methods 49:183–191[CrossRef]
National Committee for Clinical Laboratory Standards2000Performance Standard for Antimicrobial Susceptibility Testing , 5th edn. Approved standard M7-A6 Wayne, PA: National Committee for Clinical Laboratory Standards;
RogolM.,
SechterI.,
BraunsteinI.,
GerichterC. B.1983; Extended scheme for serotyping Campylobacter jejuni : results obtained in Israel from 1980 to 1981. J Clin Microbiol 18:283–286
TowbinH.,
StaehelinT.,
GordonJ.1992; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology 24:145–149